Poxel SA Cash Flow Conversion Efficiency

Latest as of June 2025: -0.124x

Poxel SA cash flow conversion efficiency. Based on the latest financial reports, Poxel SA (POXEL) has a cash flow conversion efficiency ratio of -0.124x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€7.59 Million ≈ $8.87 Million USD) by net assets (€-61.40 Million ≈ $-71.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Poxel SA (2011–2024)

Cash flow conversion efficiency of Poxel SA from 2011 to 2024. This chart illustrates how Poxel SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Poxel SA for real-time trading data and today's change.

Poxel SA Cash Flow Conversion Ratio Explained

Poxel SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Poxel SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Poxel SA ranked by their cash flow conversion efficiency. Also see POXEL market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Vaishali Pharma Limited NSE:VAISHALI	0.030x
Kim Hin Joo KLSE:0210	0.223x
Adaptimmune Therapeutics Plc NASDAQ:ADAP	0.490x
Thai Poly Acrylic Public Company Limited BK:TPA	-0.006x
Agrimin Ltd AU:AMN	-0.039x
Zhuhai Sailong Pharmaceutical Co Ltd SHE:002898	-0.076x
Esthetics International Group KLSE:5081	0.079x
Spineguard PA:ALSGD	-0.172x

Annual Cash Flow Conversion Efficiency for Poxel SA (2011–2024)

The table below shows the annual cash flow conversion efficiency of Poxel SA from 2011 to 2024. Review Poxel SA free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-58.94 Million ≈ $-68.90 Million	€-17.61 Million ≈ $-20.58 Million	0.299x	+4.88%
2023-12-31	€-49.08 Million ≈ $-57.38 Million	€-13.98 Million ≈ $-16.34 Million	0.285x	-76.18%
2022-12-31	€-18.24 Million ≈ $-21.33 Million	€-21.81 Million ≈ $-25.50 Million	1.196x	+158.09%
2021-12-31	€8.21 Million ≈ $9.59 Million	€-16.89 Million ≈ $-19.75 Million	-2.059x	-114.90%
2020-12-31	€26.88 Million ≈ $31.42 Million	€-25.75 Million ≈ $-30.10 Million	-0.958x	-45.94%
2019-12-31	€39.14 Million ≈ $45.76 Million	€-25.69 Million ≈ $-30.04 Million	-0.656x	-671.83%
2018-12-31	€55.78 Million ≈ $65.22 Million	€-4.74 Million ≈ $-5.55 Million	-0.085x	-120.23%
2017-12-31	€19.33 Million ≈ $22.60 Million	€8.13 Million ≈ $9.50 Million	0.420x	+187.86%
2016-12-31	€39.39 Million ≈ $46.05 Million	€-18.85 Million ≈ $-22.04 Million	-0.479x	-80.88%
2015-12-31	€38.03 Million ≈ $44.46 Million	€-10.06 Million ≈ $-11.76 Million	-0.265x	-111.07%
2014-12-31	€-2.55 Million ≈ $-2.98 Million	€-6.09 Million ≈ $-7.12 Million	2.390x	+614.70%
2013-12-31	€-20.01 Million ≈ $-23.39 Million	€-6.69 Million ≈ $-7.82 Million	0.334x	+101.87%
2012-12-31	€315.03K ≈ $368.30K	€-5.64 Million ≈ $-6.60 Million	-17.912x	-1489.45%
2011-12-31	€7.35 Million ≈ $8.59 Million	€-8.28 Million ≈ $-9.68 Million	-1.127x	--

About Poxel SA

PA:POXEL France Biotechnology

Market Cap

$9.54 Million

€8.16 Million EUR

Market Cap Rank

#27028 Global

#462 in France

Share Price

€0.15

Change (1 day)

-2.56%

52-Week Range

€0.13 - €0.40

All Time High

€16.30